Table of Contents
Volume 2 | Issue 1
Publication Date: April 2001- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
16 |
A Seat at the Table George W. Sledge, Jr |
|
Meeting Highlights | ||
20-26 |
2001 Highlights From: NIH Consensus Development Conference on Adjuvant Therapy for Breast Cancer, Bethesda, Maryland, November 1-3, 2000 Amy I. DOrazio |
|
Researches in Brief | ||
27-29 |
Paclitaxel in the Adjuvant Setting: Results So Far Are Inconclusive Amy I. DOrazio, I. Craig Henderson, George W. Sledge, Joyce OShaugnessy |
|
30-32 |
Is HER2/neu Overexpression a Predictor of Anthracycline Utility? Amy I. DOrazio |
|
Comprehensive Review | ||
33-36 |
Results and Implications of the Royal Marsden and Other Tamoxifen Chemoprevention Trials Paul J. Ross, Trevor J. Powles |
|
Commentaries | ||
37-38 |
Commentary on “Results and Implications of the Royal Marsden and Other Tamoxifen Chemoprevention Trials” Joseph A. Sparano |
|
39-40 |
Commentary on “Results and Implications of the Royal Marsden and Other Tamoxifen Chemoprevention Trials” Carol Fabian |
|
Comprehensive Review | ||
41-46 |
Results and Implications of the Royal Marsden and Other Tamoxifen Chemoprevention Trials: An Alternative View Joseph P. Costantino, Victor G. Vogel |
|
Original Contributions | ||
47-51 |
Activity of Pemetrexed (ALIMTA®, Multitargeted Antifolate, LY231514) in Metastatic Breast Cancer Patients Previously Treated with an Anthracycline and a Taxane: An Interim Analysis Marc Spielmann, Miguel Martin, Moïse Namer, Andreas duBois, Clemens Unger, David J. Dodwell |
|
52-58 |
Interim Analysis of the Use of the Anti-Idiotype Breast Cancer Vaccine 11D10 (TriAb®) in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer Donna E. Reece, Kenneth A. Foon, Malaya Battacharya-Chatterjee, Doug Adkins, E. Randolph Broun, D. Gerald Connaghan, John F. DiPersio, H. Kent Holland, Dianna S. Howard, Greg A. Hale, Hans G. Klingemann, Rita K. Munn, Anastasios Raptis, Gordon L. Phillips |
|
59-65 |
Assessment of Axillary Lymph Node Involvement in Small Breast Cancer: Analysis of 893 Cases Bruno Cutuli, Michel Velten, Caroline Martin |
|
Commentary | ||
66 |
Commentary on “Assessment of Axillary Lymph Node Involvement in Small Breast Cancer: Analysis of 893 Cases” Douglas Reintgen |
|
Brief Communication | ||
67-72 |
Microvessel Density and p53 Overexpression in Young Women with Breast Cancer: A Case-Control Study Barry Kalfon, Susan Fineberg, Yun Gu, Kanchana Anand, Ashish Dalal, Joan Jones, Joseph A. Sparano |
|
Translational Medicine | ||
73-79 |
Expansion of HER2/neu-Specific T Cells Ex Vivo Following Immunization with a HER2/neu Peptide-Based Vaccine Keith L. Knutson, Mary L. Disis |